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From 2008-2012, approximately 12% of colorectal cancers were diagnosed in patients 85 
years of age or older.  While this age group currently represents 2% of the U.S. population, 
it is estimated that by 2040, this age cohort will more than double in size, to over 14.7 
million.  Consequently, the number of colorectal cancers diagnosed in the elderly will rise 
steadily as well.  Cancer treatment in the elderly population poses several challenges, both 
physiologically and ethically.  While several studies have looked at elderly patients with 
colorectal cancer, few have specifically examined nonagenarians as a subgroup.  The purpose 
of our study was to examine outcomes of nonagenarians diagnosed with colorectal cancer at 
LVHN, as well as to determine some of the factors involved in the decision-making process 
regarding choice of treatment.
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Retrospective review of patients in the LVHN Tumor Registry from the 10-year 
period 2005-2014.  We identified those patients who had any surgical intervention, 
and those that chose no treatment. We then compared 1-year survival for the 2 
groups.  We also examined the factors involved in treatment decision, including 
Modified Frailty Score (MFS), presence of surrogate decision-maker, and presence 
of metastatic disease.  For those patients who chose surgical intervention, we 
examined their outcomes, including postoperative morbidity and mortality, and 
long-term survival.  Statistical analysis was performed using Chi-square analysis 
and logistic regression.
106 patients were included in the study; 71 underwent surgical intervention, 
while 35 chose no treatment.  Patients who chose surgical intervention had a 
higher 1-year survival compared to those who chose no treatment (54.9% vs 
17.1%, p<0.0005).  Metastatic disease  (p<0.0005) and presence of surrogate 
decision-maker (p=0.004) were predictive of declining treatment.  For patients 
in the surgery group, mean survival was 23.7 months, and 5-year survival 
was 9.9%.  The vast majority of the surgical patients had a procedure with 
curative intent (80.3%).  Postoperative mortality for the group was 14%, while 
morbidity was 32.4%.  Postoperative mortality for those patients undergoing 
curative surgery was 8.8%.  Increased Modified Frailty Score was not found in 
patients declining treatment or in patients with poor surgical outcomes.
Nonagenarian patients diagnosed with 
colorectal cancer have a significantly higher 
1-year survival with surgical intervention 
compared to those who decline treatment.  
Surgery can be performed in these patients 
with acceptable postoperative mortality and 
1-yr survival, especially in those patients 
having curative resection.  Modified Frailty 
Score was not useful as a predictor in 
neither treatment decision-making nor 
surgical outcomes.
POA/NOK = power of attorney or next of kin surrogate decision maker.
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Table 1: Outcomes Comparing Surgery vs No Surgery




1-yr survival 54.9% 17.1% p<0.0005
Metastatic disease 9.9% 50%
POA/NOK 7.0% 28.6% p=0.004
High-risk MFS 56.3% 48.6% ns
Assisted living 21.1% 31.4% ns
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